Terms & conditions
Terms & conditions
This website is designed in the United Kingdom and is for information purposes only and is not an advertisement. Nothing on this site constitutes a binding offer to perform any service.
Although we have taken care over what is said in this website, any advice contained in the website is of a generic nature only. Any reliance by you on such advice or any information in the site is entirely at your own risk and we do not accept any liability to any person who relies on it.
We are not responsible for the content of any other site (website, blog, social media or other), including any site through which you may have gained access to this website or to which you may gain access from this website. We do not accept any liability in connection with any such sites or links.
Copyright
You are responsible for obeying all applicable copyright laws. We permit you to make copies of this site as necessary incidental acts during your viewing of it; and you may take a print for your personal use of so much of the site as is reasonable for private purposes, but you must not otherwise copy it, use it or re-publish it in whole or in part (including by linking or framing) without this “Disclaimer” section nor without first obtaining written consent from I C Consultants Ltd.
© I C Consultants Ltd. All rights reserved, and all moral rights are asserted and reserved.
Latest news, insights and events

Discovery Channel’s ‘Breaking Magic’
Dr Roberto Trotta provided scientific expertise to the production team of ‘Breaking Magic’, which airs on the Discovery Channel. read more

Improving service through bus priority schemes
Transport Strategy Centre (RTSC) study investigates the use of priority measures for bus services in 14 cities across Asia, Australia, Europe and North America and provides best practice for decision makers charged with improving service and efficiency. read more

Cystic Fibrosis expert from Imperial named on clinical advisory board for Proteostasis Therapeutics
Professor Jane Davies of Imperial College London has been appointed to Proteostasis Therapeutics’ Cystic Fibrosis clinical advisory board, in a collaboration facilitated by Imperial Consultants (ICON). read more